Web Results

OSI Pharmaceuticals

en.wikipedia.org/wiki/OSI_Pharmaceuticals

OSI Pharmaceuticals, Inc. is an American pharmaceutical company based in Long Island, New York with facilities in Colorado, New Jersey and the United ...

Astellas Pharma US, Inc. | R&D

www.astellas.us/therapeutic/rnd/Index.aspx

Agensys, Inc., a subsidiary of Astellas Pharma Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers.

BioSpace - OSI Pharma News, Search Jobs, Events

www.biospace.com/company_profile.aspx?CompanyId=1464

About OSI Pharmaceuticals OSI Pharmaceuticals, acquired by Astellas Pharma Inc. in 2010, is a leading biotechnology company focused on the discovery and ...

2016 OSI Pharmaceuticals, LLC, an affiliate of Astellas ... - Tarceva

www.tarceva.com/patient/copyright

Genentech USA, Inc. and Astellas Pharma US, Inc. hereby authorize you to copy documents or pages published by Genentech USA, Inc. and Astellas Pharma ...

OSI Pharmaceuticals Announces Acceptance of a Tarceva(R ...

www.us.astellas.com/docs/us/OSIP_News_2009_7_6_General_Releases.pdf?v=1

OSI Pharmaceuticals Announces Acceptance of a Tarceva(R) Supplemental New Drug. Application in Pancreatic Cancer for Review by the U.S. Food and Drug ...

OSI Pharmaceuticals Inc.: Private Company Information ... - Bloomberg

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=293711

As of May, 2013, OSI Pharmaceuticals Inc. went out of business. OSI Pharmaceuticals Inc. offers oncology drug discovery and translational research services ...

OSI Pharmaceuticals closes LI facility | Newsday

www.newsday.com/business/osi-pharmaceuticals-closes-li-facility-1.5252128

May 13, 2013 ... OSI Pharmaceuticals, once the bright hope in Long Island's struggle to build a bioscience industry, is shuttering its remaining facility in the ...

Genentech: Press Releases | OSI Pharmaceuticals and Genentech ...

www.gene.com/media/press-releases/7527/2004-06-16/osi-pharmaceuticals-and-genentech-enter-

Jun 16, 2004 ... OSI Pharmaceuticals and Genentech Enter into Co-Promotion and Manufacturing Agreements for Tarceva. Melville, N.Y. and South San ...

Genentech: Press Releases | OSI Pharmaceuticals, Genentech and ...

www.gene.com/media/press-releases/4639/2001-01-08/osi-pharmaceuticals-genentech-and-roche-

Jan 8, 2001 ... OSI Pharmaceuticals, Genentech and Roche Team up to Deveolp and Commercialize OSI-774, OSI's Leading Cancer Drug to Develop and ...

OSI Pharmaceuticals Inc. - Company Profile - BioCentury

www.biocentury.com/companies/osi_pharmaceuticals_inc

OSI's detailed financings; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma industry analysis.

More Info

OSI Pharma, Long Island Biotech Bellwether, Shut Down by Astellas ...

www.xconomy.com

May 14, 2013 ... OSI Pharmaceuticals became the home-grown beacon of Long Island, NY's biotech scene behind the lung cancer drug erlotinib (Tarceva), ...

Astellas buys OSI Pharma for $4 billion in cancer push | Reuters

www.reuters.com

May 17, 2010 ... Astellas Pharma (4503.T), Japan's No. 2 drugmaker, agreed to buy U.S. biotech OSI Pharmaceuticals OSIP.O for $4 billion in cash in a ...

OSI Pharmaceuticals LLC :: Company Profiles :: Pharma & Medtech ...

www.pharmamedtechbi.com

OSI Pharmaceuticals LLC. / www.osip.com. A Division of Astellas Pharma Inc. / Company # 198600253. + Show All | – Hide All ...